Trial Profile
Effects of Evolocumab on carotid plaque.
Status:
Discontinued
Phase of Trial:
Phase II
Latest Information Update: 15 Jul 2019
Price :
$35
*
At a glance
- Drugs Evolocumab (Primary)
- Indications Atherosclerosis
- Focus Therapeutic Use
- 13 Jul 2019 Status has been changed to discontinued.
- 03 Aug 2017 New trial record